Current Opinion in Infectious Diseases

Article	Citations
Aspergillus fumigatus and pan-azole resistance: who should be concerned?	54
Update on group A streptococcal vaccine development	51
Artemisinin and multidrug-resistant Plasmodium falciparum – a threat for malaria control and elimination	48
Current choices of antibiotic treatment for Pseudomonas aeruginosa infections	46
Skin manifestations of Pseudomonas aeruginosa infections	46
Central nervous system infections produced by varicella zoster virus	45
COVID-19 in children: current evidence and key questions	45
Sapovirus: an emerging cause of childhood diarrhea	40
Pediatric acute gastroenteritis associated with adenovirus 40/41 in low-income and middle-income countries	38
Treatment of multidrug-resistant Gram-negative skin and soft tissue infections	37
New treatment options for multiresistant gram negatives	36
Giardiasis treatment: an update with a focus on refractory disease	34
Mucosal immunity to severe acute respiratory syndrome coronavirus 2 infection	33
Continuous versus intermittent infusion of antibiotics in Gram-negative multidrug-resistant infections	28
Tuberculous meningitis: where to from here?	27
Updates on defining and detecting diarrheagenic Escherichia coli pathotypes	24
Antimicrobial-resistant bacteria in international travelers	24
Parental vaccine hesitancy: scope, causes, and potential responses	23
Techniques in bacterial strain typing: past, present, and future	21
Long COVID in children and adolescents	21
Zoonoses and global epidemics	19
Risks of metabolic syndrome and diabetes with integrase inhibitor-based therapy	19
Infections after anti-CD19 chimeric antigen receptor T-cell therapy for hematologic malignancies: timeline, prevention, and uncertainties	19
Scrub typhus: a reemerging infection	18
Potential and demonstrated impacts of the COVID-19 pandemic on sexually transmissible infections	18

MDRO transmission in acute hospitals during the COVID-19 pandemic	17
Epstein–Barr virus posttransplant lymphoproliferative disorder: update on management and outcomes	17
Emerging treatment options for cryptosporidiosis	16
Methicillin-resistant Staphylococcus aureus lung infection in coronavirus disease 2019: how common?	16
New drugs for methicillin-resistant Staphylococcus aureus skin and soft tissue infections	16
Final frontiers of the polio eradication endgame	16
Prolonged infusion of beta-lactam antibiotics for Gram-negative infections: rationale and evidence base	16
Choosing antibiotic therapy for severe community-acquired pneumonia	16
Gram-negative endocarditis: disease presentation, diagnosis and treatment	15
Biotypes of HIV-associated neurocognitive disorders based on viral and immune pathogenesis	15
Coronavirus disease 2019 vaccination in transplant recipients	15
Policy and planning for large epidemics and pandemics – challenges and lessons learned from COVID-19	15
Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside	15
Predictors of multidrug resistant Pseudomonas aeruginosa involvement in bloodstream infections	14
Community-acquired pneumonia in chronic obstructive pulmonary disease	14
Fungal infections of the skin and soft tissue	14
The role of multidrug and extensive-drug resistant Gam-negative bacteria in skin and soft tissue infections	14
New testing guidelines for community-acquired pneumonia	13
Subarachnoid neurocysticercosis: emerging concepts and treatment	13
Update on cytomegalovirus in transplant recipients: new agents, prophylaxis, and cell-mediated immunity	13
Nebulized antibiotics for ventilator-associated pneumonia: methodological framework for future multicenter randomized controlled trials	13
Clinical and economic impact of bacterial resistance: an approach to infection control and antimicrobial stewardship solutions	12
COVID-19 transmission and the safety of air travel during the pandemic: a scoping review	12
Melioidosis and Burkholderia pseudomallei: progress in epidemiology, diagnosis, treatment and vaccination	12
Unresolved issues in the identification and treatment of carbapenem-resistant Gram-negative organisms	12
Choice and duration of antifungal prophylaxis and treatment in high-risk haematology patients	11
Long-acting injectable HIV therapies: the next frontier	11
Asymptomatic bacteriuria and urinary tract infections in kidney transplant recipients	11
Role of new antibiotics in the treatment of acute bacterial skin and skin-structure infections	11
Optimizing aerosol delivery of antibiotics in ventilated patients	11
Bacteriophage therapy as a treatment option for transplant infections	11
Advances in the diagnosis and treatment of latent tuberculosis infection	11
Nonviral sexually transmitted infections in pregnancy: current controversies and new challenges	11
Diagnosis of invasive fungal disease in coronavirus disease 2019: approaches and pitfalls	10
Antibiotic treatment of common infections: more evidence to support shorter durations	10
Mycobacterial skin infection	10
Prevention of SARS-CoV-2 and respiratory viral infections in healthcare settings: current and emerging concepts	10
Dengue vaccine development: challenges and prospects	10
Mind the gaps: challenges in the clinical management of invasive candidiasis in critically ill patients	10
What will it take to meet UNAIDS targets for preexposure prophylaxis users?	10
Typhoid fever control in the 21st century: where are we now?	10
Infections associated with the new ‘nibs and mabs’ and cellular therapies	10
Risk stratification for multidrug-resistant bacteria in patients with skin and soft tissue infection	10
What is new with hand hygiene?	10
Immunocompromised host section: Adoptive T-cell therapy for dsDNA viruses in allogeneic hematopoietic cell transplant recipients	10
Neurologic aspects of coronavirus disease of 2019 infection	10
Role of new antibiotics in extended-spectrum β-lactamase-, AmpC- infections	9
Staphylococcus aureus infections in children	9
Invasive aspergillosis in coronavirus disease 2019: a practical approach for clinicians	9
Hospital water as the source of healthcare-associated infection and antimicrobial-resistant organisms	9

Immunotherapeutic approaches to HIV cure and remission	9
Viral meningitis and encephalitis: an update	9
Neuroradiology of infectious diseases	9
Clinical application of non-coding RNAs in sepsis	9
Emergence of a novel urogenital-tropic Neisseria meningitidis	9
Skin manifestations in patients with coronavirus disease 2019	9
Frailty in people living with HIV: an update	9
Duration of antibiotic therapy in central venous catheter-related bloodstream infection due to Gram-negative bacilli	8
Effects of HIV voluntary medical male circumcision programs on sexually transmitted infections	8
New trends in congenital syphilis: epidemiology, testing in pregnancy, and management	8
Siderophores: a potential role as a diagnostic for invasive fungal disease	8
Dose optimisation of antibiotics used for meningitis	8
Treatment of extended-spectrum β-lactamases infections: what is the current role of new β-lactams/β-lactamase inhibitors?	8
The role of new antimicrobials for Gram-negative infections in daily clinical practice	8
Management dilemmas in Nocardia brain infection	8
CNS infections in HIV	8
Hyperammonemia syndrome in immunosuppressed individuals	8
Drivers of melioidosis endemicity: epidemiological transition, zoonosis, and climate change	8
Managing uncertainty in antifungal dosing: antibiograms, therapeutic drug monitoring and drug-drug interactions	7
Duration of antibiotic therapy in Gram-negative infections with a particular focus on multidrug-resistant pathogens	7
Pneumonia in older adults	7
Giardia and growth impairment in children in high-prevalence settings: consequence or co-incidence?	7
Respiratory metagenomics: route to routine service	7
Coronavirus disease 2019 in children	7
The skin and soft tissue infections in hematological patients	7
Biomarkers in sepsis: can they help improve patient outcome?	7
Bacterial RTX toxins and host immunity	7
Noninvasive ventilation and high-flow oxygen therapy for severe community-acquired pneumonia	7
Nontyphoidal Salmonella infections acquired from poultry	7
Tick-borne encephalitis	7
Multidrug-resistant, gram-negative infections in high-risk haematologic patients: an update on epidemiology, diagnosis and treatment	7
Antibody glycosylation in pregnancy and in newborns: biological roles and implications	7
When should we use corticosteroids in severe community-acquired pneumonia?	6
Severe acute respiratory syndrome coronavirus 2 infection in the stem cell transplant recipient − clinical spectrum and outcome	6
Unraveling Haemophilus influenzae virulence mechanisms enable discovery of new targets for antimicrobials and vaccines	6
Cytomegalovirus in primary immunodeficiency	6
Neonatal bloodstream infections	6
The microbiota in respiratory tract infections: from association to intervention	6
Congenital Chagas disease: progress toward implementation of pregnancy-based screening	6
The role of Gram-negative bacteria in skin and soft tissue infections	6
Current international and national guidelines for managing skin and soft tissue infections	6
Brain calcification because of neurocysticercosis: a vast field to be explored	6
Role or oritavancin and dalbavancin in acute bacterial skin and skin structure infections and other potential indications	6
The infant pharyngeal microbiomes: origin, impact and manipulation	6
How common is ventilator-associated pneumonia after coronavirus disease 2019?	6
Laboratory-developed test regulation and the immunocompromised patient: uncertainty ahead	6
Managing and preventing exacerbation of bronchiectasis	6
New antibiotics for the treatment of nonfermenting Gram-negative bacteria	6
Monoclonal antibodies for prophylaxis and treatment of respiratory viral infections	6
Biomarkers to predict cardiovascular disease in people living with HIV	6
Drug resistance in Salmonella Typhi: implications for South Asia and travel	6
Alveolar echinococcosis: what triggers emergence in North America, Central Europe and Asia?	6
Current opinion in management of septic shock due to Gram-negative bacteria	6
Current management of necrotizing soft-tissue infections	6
Beyond antivirals: virus-specific T-cell immunotherapy for BK virus haemorrhagic cystitis and JC virus progressive multifocal leukoencephalopathy	6
Escherichia coli 0157:H7 virulence factors and the ruminant reservoir	6
Arboviral central nervous system infections	6
Potential role of new-generation antibiotics in acute bacterial skin and skin structure infections	6
Antimicrobial use in central nervous system infections	5
Update on nonantibiotic therapies for acute gastroenteritis	5
Host transcriptional signatures as predictive markers of infection in children	5
Amebic encephalitis and meningoencephalitis: an update on epidemiology, diagnostic methods, and treatment	5
Pulmonary infections in the hematopoietic cell transplant patient	5
The implications of the COVID-19 pandemic for long term care facilities	5
Predisposition of COVID-19 patients to secondary infections: set in stone or subject to change?	5
The impact of alteration in gut microbiome in the pathogenesis of nonalcoholic fatty liver disease	5
New management approaches to tuberculosis in people living with HIV	5
Conjunctival cancer in people living with HIV	5
Central nervous system infections after solid organ transplantation	5
Rectal chlamydia infections: implications for reinfection risk, screening, and treatment guidelines	5
Echocardiography and FDG-PET/CT scan in Gram-negative bacteremia and cardiovascular infections	5
Updates on the epidemiology, pathogenesis, diagnosis, and management of postinfectious irritable bowel syndrome	5
Prevention strategies for congenital cytomegalovirus infection	5
Global health security as it pertains to Zika, Ebola, and COVID-19	5
Antibiotic treatment of acute bacterial skin and skin structure infections	5
Respiratory syncytial virus infection in the modern era	5
The current state of immunization against Gram-negative bacteria in children: a review of the literature	5
Novel strategies for prevention and treatment of antimicrobial resistance in sexually-transmitted infections	5
Lenacapavir and the novel HIV-1 capsid inhibitors: an emerging therapy in the management of multidrug-resistant HIV-1 virus	5
mRNA vaccines against respiratory viruses	5

Molecular diagnostic methods for pneumonia: how can they be applied in practice?	5
The intracellular phase of extracellular respiratory tract bacterial pathogens and its role on pathogen-host interactions during infection	5
Recent concepts in fungal involvement in skin and soft tissue infections	4
Radiology-based diagnosis of fungal pulmonary infections in high-risk hematology patients: are we making progress?	4
Skin and soft tissue infections due to rapidly growing mycobacteria	4
Novel agents in development for multidrug-resistant Gram-negative infections: potential new options facing multiple challenges	4
Gastrointestinal manifestations of coronavirus disease 2019	4
Gram-negative bacteria as a cause of mediastinitis after cardiac surgery	4
Beyond personal protective equipment: adjunctive methods for control of healthcare-associated respiratory viral infections	4
Progress and challenges in human papillomavirus and cervical cancer in southern Africa	4
Anatomical site-specific immunomodulation by bacterial biofilms	4
Mycetoma, chromoblastomycosis and other deep fungal infections: diagnostic and treatment approach	4
Resistant herpes simplex virus infections – who, when, and what's new?	4
Community-acquired skin and soft-tissue infections in people who inject drugs	3
Antiviral therapies for influenza	3
Sequence-based diagnostics and precision medicine in bacterial and viral infections: from bench to bedside	3
Cotrimoxazole and clindamycin in skin and soft tissue infections	3
Acute infectious myelopathies	3
Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-19	3
Diagnostic approach and update on encephalitis	3
How to use new antibiotics in the therapy of serious multidrug resistant Gram-negative infections?	3
Endemic, epidemic and pandemic infections: the roles of natural and acquired herd immunity	3
Modeling transmission of pathogens in healthcare settings	3
The future of Clostridioides difficile diagnostics	3
Clinical evidence supporting cefiderocol for serious Acinetobacter baumannii infections	3
Neurocysticercosis: an update on diagnosis, treatment, and prevention	3
Machine learning and artificial intelligence for the diagnosis of infectious diseases in immunocompromised patients	3
Updates in central nervous system malaria: literature review and considerations	3
Human herpesvirus 8 and Kaposi sarcoma: how should we screen and manage the transplant recipient?	3
Advances and challenges in sexually transmitted infections prevention among men who have sex with men in Asia	3
Resistance in Enteric Shigella and nontyphoidal Salmonella: emerging concepts	3
Mitigation of nontuberculous mycobacteria in hospital water: challenges for infection prevention	3
Neurodevelopmental outcomes in congenital and perinatal infections	3
The interplay between acute bacterial skin and skin structure infections and depression: a vicious circle of major clinical importance	3
Empirical antibiotic therapy for difficult-to-treat Gram-negative infections: when, how, and how long?	3
Transplantation for chagas’ disease: closing the knowledge gap	3
Contributions of Yersinia pestis outer membrane protein Ail to plague pathogenesis	3
Where was my patient born? The Intersection of tropical medicine and migrant health	3
The eternal dilemma of antitoxin antibiotics for skin and soft tissue infection	3
Duration of antimicrobial therapy for Gram-negative infections	3
The impact of coronavirus disease 2019 on people with HIV	3
New evidence for managing Gram-negative bloodstream infections	3
New approaches to management of fever and neutropenia in high-risk patients	3
Pregnancy and malaria: the perfect storm	3
Shifting the power: scale-up of access to point-of-care and self-testing for sexually transmitted infections in low-income and middle-income settings	3